IMIQUIMOD News

IMIQUIMOD currently has 8 news articles, with 21 predicted indications.

This page combines the AI-predicted indications for IMIQUIMOD with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (21):
- melanoacanthoma (99.0%)
- anogenital human papillomavirus infection (99.0%)
- superficial multifocal basal cell carcinoma (99.0%)
- epidermodysplasia verruciformis (99.0%)
- common wart (99.0%)
- inverted follicular keratosis (99.0%)
- actinic cheilitis (99.0%)
- skin disease (99.0%)
- keratoacanthoma (99.0%)
- actinic keratosis (disease) (99.0%)
- seborrheic keratosis (99.0%)
- pre-malignant neoplasm (99.9%)
- benign neoplasm of buccal mucosa (99.9%)
- cervical neuroblastoma (99.9%)
- odontogenic cyst (99.9%)
- benign neoplasm of tongue (99.9%)
- nasopharyngeal teratoma (99.9%)
- cystic neoplasm (99.9%)
- inner ear neoplasm (99.9%)
- neoplasm of major salivary gland (99.9%)
- schwannoma of jugular foramen (99.9%)